These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36528541)

  • 41. Brain penetration effects of microelectrodes and DBS leads in STN or GPi.
    Mann JM; Foote KD; Garvan CW; Fernandez HH; Jacobson CE; Rodriguez RL; Haq IU; Siddiqui MS; Malaty IA; Morishita T; Hass CJ; Okun MS
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):794-7. PubMed ID: 19237386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome.
    van Horne CG; Quintero JE; Slevin JT; Anderson-Mooney A; Gurwell JA; Welleford AS; Lamm JR; Wagner RP; Gerhardt GA
    J Neurosurg; 2018 Dec; 129(6):1550-1561. PubMed ID: 29451447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial.
    Kefalopoulou Z; Zrinzo L; Jahanshahi M; Candelario J; Milabo C; Beigi M; Akram H; Hyam J; Clayton J; Kass-Iliyya L; Silverdale M; Evans J; Limousin P; Hariz M; Joyce E; Foltynie T
    Lancet Neurol; 2015 Jun; 14(6):595-605. PubMed ID: 25882029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
    Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.
    Katz M; Luciano MS; Carlson K; Luo P; Marks WJ; Larson PS; Starr PA; Follett KA; Weaver FM; Stern MB; Reda DJ; Ostrem JL;
    Ann Neurol; 2015 Apr; 77(4):710-9. PubMed ID: 25627340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early versus Late Application of Subthalamic deep brain Stimulation to Parkinson's disease patients with motor complications (ELASS): protocol of a multicentre, prospective and observational study.
    Jiang L; Poon WS; Moro E; Xian W; Yang C; Zhu XL; Gu J; Cai X; Liu J; Mok V; Liu Y; Xu S; Guo Q; Chen W; Chen L
    BMJ Open; 2017 Nov; 7(11):e018610. PubMed ID: 29150478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility of movement disorder society-unified Parkinson's disease rating scale for evaluating effect of subthalamic nucleus deep brain stimulation.
    Yamamoto T; Yamanaka Y; Hirano S; Higuchi Y; Kuwabara S
    Front Neurol; 2022; 13():1042033. PubMed ID: 36686507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination targeting of subthalamic nucleus and ventral intermediate thalamic nucleus with a single trajectory in deep brain stimulation for tremor-dominant Parkinson's disease.
    Fayed I; Cobourn KD; Pivazyan G; Torres-Yaghi YA; Pagan FL; Lo SE; Mandir AS; Kalhorn CG
    J Clin Neurosci; 2021 Mar; 85():92-100. PubMed ID: 33581797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects.
    Kirsch AD; Hassin-Baer S; Matthies C; Volkmann J; Steigerwald F
    Parkinsonism Relat Disord; 2018 Oct; 55():61-67. PubMed ID: 29784559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous bilateral stereotactic procedure for deep brain stimulation implants: a significant step for reducing operation time.
    Fonoff ET; Azevedo A; Angelos JS; Martinez RC; Navarro J; Reis PR; Sepulveda ME; Cury RG; Ghilardi MG; Teixeira MJ; Lopez WO
    J Neurosurg; 2016 Jul; 125(1):85-9. PubMed ID: 26684776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial.
    Oliveria SF; Rodriguez RL; Bowers D; Kantor D; Hilliard JD; Monari EH; Scott BM; Okun MS; Foote KD
    Lancet Neurol; 2017 Sep; 16(9):691-700. PubMed ID: 28642125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short Versus Conventional Pulse-Width Deep Brain Stimulation in Parkinson's Disease: A Randomized Crossover Comparison.
    Dayal V; Grover T; Tripoliti E; Milabo C; Salazar M; Candelario-McKeown J; Athauda D; Zrinzo L; Akram H; Hariz M; Limousin P; Foltynie T
    Mov Disord; 2020 Jan; 35(1):101-108. PubMed ID: 31571270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease.
    Fabbri M; Coelho M; Guedes LC; Rosa MM; Abreu D; Gonçalves N; Antonini A; Ferreira JJ
    Parkinsonism Relat Disord; 2017 Aug; 41():113-117. PubMed ID: 28528805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. STN versus GPi deep brain stimulation for dyskinesia improvement in advanced Parkinson's disease: A meta-analysis of randomized controlled trials.
    Zhang J; Li J; Chen F; Liu X; Jiang C; Hu X; Ma L; Xu Z
    Clin Neurol Neurosurg; 2021 Feb; 201():106450. PubMed ID: 33421741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal target localisation and eight-year outcome for subthalamic stimulation in patients with Parkinson's disease.
    Guo S; Li J; Zhang Y; Li Y; Zhuang P
    Br J Neurosurg; 2021 Apr; 35(2):151-156. PubMed ID: 32532160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved accuracy using a modified registration method of ROSA in deep brain stimulation surgery.
    Xu F; Jin H; Yang X; Sun X; Wang Y; Xu M; Tao Y
    Neurosurg Focus; 2018 Aug; 45(2):E18. PubMed ID: 30064312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.
    Knudsen K; Krack P; Tonder L; Houeto JL; Rau J; Schade-Brittinger C; Hartmann A; Hälbig TD; Paschen S; Barbe MT; Kühn A; Fraix V; Brefel-Courbon C; Vesper J; Maltête D; Sixel-Döring F; Weiss D; Witjas T; Thobois S; Agid Y; Schnitzler A; Schuepbach WMM; Timmermann L; Damier P; Vidailhet M; Deuschl G;
    Parkinsonism Relat Disord; 2019 Aug; 65():217-223. PubMed ID: 31257096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease.
    Li H; Liang S; Yu Y; Wang Y; Cheng Y; Yang H; Tong X
    PLoS One; 2020; 15(9):e0238936. PubMed ID: 32915893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.